URO-1, a Greensboro medical device company specialized in prostate and soft tissue cancer diagnostics, is expanding its ...
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
— Clinical evidence continues to highlight TULSA’s ability to treat an unrivalled variety of patients with localized prostate cancer and/or BPH — “The various presentations made at AUA and other major ...
After skin cancer, prostate cancer is the most common cancer among men in the U.S., and 20% to 30% of men who beat it once will face a recurrence within five years. A new treatment, known as salvage ...
BEXAR COUNTY, Texas – Bexar County Judge Peter Sakai announced he will be taking a brief recovery period after a medical procedure over the holidays. In an online video, Sakai let the public know that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results